Tehran (IP) - The spokesman of the Iran Food and Drug Administration (IFDA) said a shipment of 100,000 doses of Cuban-Iranian vaccine for phase 3 of the clinical trials have arrived in Iran from Cuba.

Iran Press/Iran News: The shipment arrived at the Imam Khomeini International Airport in Tehran on Thursday.

Earlier, the IFDA spokesman Kianoush Jahanpour had said Cuba was preparing for a Phase III clinical trial of the coronavirus vaccine with 150,000 participants. 50,000 people in Iran are participating in this phase (Phase III clinical trial of coronavirus vaccine). It is noteworthy that the clinical trial of this vaccine in children and adolescents will also begin in Cuba.

Iran and Cuba signed an agreement in January to cooperate in the coronavirus vaccine project with the use of a technology that will be transferred to Iran by the Cuban government.

Iran has three major vaccine candidates to tackle one of the largest outbreaks of the pandemic in the Middle East region. The country started vaccinating frontline health workers earlier this month using jabs imported from Russia.

Iran’s Pasteur Institute and Cuba’s Finlay Vaccine Institute are planned to finish the third phase of human trials for Soberana 2, an advanced vaccine that will be tested on 50,000 Iranians, until late March. The Cuban side has committed to technology transfer and joint production of the vaccine in Iran.


Read More:

Iran, Cuba to produce millions of doses of coronavirus vaccine